CXCL13 and non-small cell lung carcinoma: The crucial role of the chemokine CXCL13 has been demonstrated in non-small cell lung cancer and esophageal squamous cell carcinoma, while its predictive role in neoadjuvant immunotherapy for CRC remains to be explored (55, 56).